Weaver Consulting Group’s CRISPR Therapeutics CRSP Stock Holding History

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-150	Closed	-$13K	–	289
2020 Q3	$13K	Hold	150	–	–	0.01%	486
2020 Q2	$11K	Buy	+150	New	+$11K	0.01%	498